Abstract
C4H2N3BrO4·H2O, monoclinic, P21/c (no. 14), a = 7.177(2) Å, b = 10.999(3) Å, c = 10.414(3) Å, β =

1 Source of materials
4-bromo-3-nitro-1H-pyrazole-5-carboxylic acid (L) was dissolved in a warm ethanol and added to a warm ethanol solution of Zn(NO3)2·6H2O in a molar ratio of 1:2. Colorless solution was left to crystallize. After two days, the colorless single crystals of the title compound (L·H2O) were filtered and washed with ethanol. L and Zn(NO3)2·6H2O were purchased from Sigma-Aldrich.
2 Experimental details
The N-bound H atom were positioned geometrically and included as riding atom with Uiso(H) set to 1.2Ueq(N). The H atom of the hydroxyl group was allowed to rotate around the C–O bond, with O–H distance refined to best fit the experimental electron density (HFIX 148 in the SHELX program suite [2], with Uiso(H) set to 1.5Ueq(O). Hydrogen atoms from water were located from a difference-Fourier map and their positions were refined with Uiso(H) set to 1.5Ueq(O) (Tables 1 and 2).
Data collection and handling.
Crystal: | Stick, colorless |
Size: | 0.15 × 0.10 × 0.10 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 5.08 mm−1 |
Diffractometer, scan mode: | Bruker APEX-II, φ and ω-scans |
θmax, completeness: | 26.4°, >99% |
N (hkl)measured, N(hkl)unique, Rint: | 16034, 1646, 0.048 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 1323 |
N(param)refined: | 126 |
Programs: | Bruker programs [1], SHELX [2], Mercury [3], PLATON [4], WinGX [5, 6] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
x | y | z | Uiso*/Ueq | |
---|---|---|---|---|
Br1 | 0.20057 (6) | 0.88241 (3) | 0.49285 (4) | 0.04232 (15) |
O1 | 0.4727(4) | 0.8378(2) | 0.7732(3) | 0.0384(7) |
O2 | 0.5981(4) | 0.6531(2) | 0.8218(3) | 0.0395(7) |
H2 | 0.652(6) | 0.686(2) | 0.885(4) | 0.059* |
O3 | 0.0057(5) | 0.7041(3) | 0.2786(3) | 0.0559(9) |
O4 | 0.0196(5) | 0.5080(3) | 0.2865(3) | 0.0541(9) |
N1 | 0.3681(4) | 0.5500(3) | 0.6203(3) | 0.0284(7) |
H1 | 0.4333 | 0.4994 | 0.6764 | 0.034* |
N2 | 0.2571(4) | 0.5140(3) | 0.5108(3) | 0.0299(7) |
N3 | 0.0609(5) | 0.6083(3) | 0.3309(3) | 0.0366(8) |
C3 | 0.1877(5) | 0.6175(3) | 0.4560(3) | 0.0276(8) |
C4 | 0.2516(5) | 0.7195(3) | 0.5292(3) | 0.0264(8) |
C5 | 0.3709(5) | 0.6720(3) | 0.6368(3) | 0.0257(8) |
C6 | 0.4857(5) | 0.7309(3) | 0.7511(3) | 0.0290(8) |
O5 | 0.7550(5) | 0.7563(3) | 1.0365(3) | 0.0442(8) |
H3 | 0.765(7) | 0.827(5) | 1.037(5) | 0.066* |
H4 | 0.822(7) | 0.731(5) | 1.090(5) | 0.066* |
3 Comment
The pyrazoles possess many biological and pharmaceutical properties [7]. They also have interesting coordination properties [8]. Important use of pyrazole complexes is in the extraction of metal ions [9]. Pyrazoles are also important for the synthesis of metal-organic frameworks [10]. Supramolecular aspect is important for understanding of the pyrazoles chemistries [11]. Main driving force for self-assembly of pyrazolyl molecules are hydrogen bonds [12]. Pyrazolyl molecules crystallize in a variety of motifs determined by N–H··N hydrogen bonds [13]. Capacity for nonbonding interaction of substituents additionally influences the aggregation of pyrazole derivatives [14]. Halogen bonding can be competitive to hydrogen bonding [15]. Both interactions are possible in the halogenated pyrazoles. As a continuation of our previous work [16], [17], [18], [19] we report molecular and crystal structure of 4-bromo-3-nitro-1H-pyrazole-5-carboxylic acid monohydrate. Title pyrazolyl compound (L) exhibits high capacity for non-covalent bonding. COOH, N–H··O/N [20], NO2 [21] and Br [22] can form hydrogen bonds. Br atoms can form Br··Br contacts of non-covalent nature [23]. The ORTEP diagram in the upper part of the figure depicts assymetric unit and atom labeling. Hydrogen bonds N1–H1··O1i = 1.94 Å/
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: None declared.
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
1. Bruker. Apex2, Saint and Sadabs. Bruker AXS Inc., Madison, Wisconsin, USA, 2009.Suche in Google Scholar
2. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2014, C71, 3–8, https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar
3. Macrae, C. F., Edgington, P. R., McCabe, P., Pidcock, E., Shields, G. P., Taylor, R., van der Streek, T., van de Streek, J. Mercury: visualization and analysis of crystal structures. J. Appl. Crystallogr. 2020, 39, 453–457; https://doi.org/10.1107/s002188980600731x.Suche in Google Scholar
4. Spek, A. L. Single-crystal structure validation with the program PLATON. J. Appl. Crystallogr. 2003, 36, 7–13; https://doi.org/10.1107/s0021889802022112.Suche in Google Scholar
5. Farrugia, L. J. WinGX suite for small-molecule single-crystal crystallography. J. Appl. Crystallogr. 1999, 32, 837–838; https://doi.org/10.1107/s0021889899006020.Suche in Google Scholar
6. Farrugia, L. J. WinGX and ORTEP for windows: an update. J. Appl. Crystallogr. 2012, 45, 849–854; https://doi.org/10.1107/s0021889812029111.Suche in Google Scholar
7. Alam, J., Alam, O., Alam, P., Naim, M. J. A review on pyrazole chemical entity and biological activity. Int. J. Pharm. Sci. Res. 2015, 6, 1433–1442.Suche in Google Scholar
8. Zou, R.-Q., Liu, C.-S., Shi, X.-S., Buab, X.-H., Ribas, J. Tuning the topologies of MnII complexes with 3-(2-pyridyl)pyrazole and carboxylate ligands by intramolecular hydrogen bonds and the geometries of pendant ligands: crystal structures and magnetic properties. CrystEngComm 2005, 7, 722–727; https://doi.org/10.1039/b513269j.Suche in Google Scholar
9. Attayibat, A., Radi, S., Lekchiri, Y., Ramdani, A., Hacht, B., Bacquet, M., Willai, S., Morcellet, M. New functionalised C,C bipyrazoles. Synthesis and cation binding properties. J. Chem. Res. 2006, 10, 655–657; https://doi.org/10.3184/030823406779173587.Suche in Google Scholar
10. Pettinari, C., Tabacaru, A., Galli, S. Coordination polymers and metal-organic frameworks based on poly(pyrazole)-containing ligands. Coord. Chem. Rev. 2016, 307, 1–31; https://doi.org/10.1016/j.ccr.2015.08.005.Suche in Google Scholar
11. Pérez, J., Riera, L. Pyrazole complexes and supramolecular chemistry. Eur. J. Inorg. Chem. 2009, 2009, 4913–4925; https://doi.org/10.1002/ejic.200900694.Suche in Google Scholar
12. Infantes, L., Motherwell, S. Prediction of H-bonding motifs for pyrazoles and oximes using the Cambridge structural database. Struct. Chem. 2004, 15, 173–184; https://doi.org/10.1023/b:stuc.0000021525.74750.fa.10.1023/B:STUC.0000021525.74750.faSuche in Google Scholar
13. Foces-Foces, C. N., Alkorta, I., Elguero, J. Supramolecular structure of 1H-pyrazoles in the solid state: a crystallographic and ab initio study. Acta Crystallogr., Sect. B: Struct. Sci. 2000, 56, 1018–1028; https://doi.org/10.1107/s0108768100008752.Suche in Google Scholar PubMed
14. Padilla-Martinez, I. I., Flores-Larios, I. Y., García Baez, E., Gonzalez, J., Cruz, A., Martinez-Martinez, F. J. X-Ray supramolecular structure, NMR spectroscopy and synthesis of 3-methyl-1-phenyl-1H-chromeno[4,3-c] pyrazol-4-ones formed by the unexpectedcCyclization of 3-[1-(phenylhydrazono)ethyl]-chromen-2-ones. Molecules 2011, 16, 915–932; https://doi.org/10.3390/molecules16010915.Suche in Google Scholar PubMed PubMed Central
15. Durka, K., Lulinski, S., Jarzembska, K. N., Smetek, J., Serwatowskia, J., Wozniak, K. Competition between hydrogen and halogen bonding in the structures of 5,10-dihydroxy-5,10- dihydroboranthrenes. Acta Cryst 2014, B70, 157–171; https://doi.org/10.1107/s2052520613034987.Suche in Google Scholar PubMed
16. Jaćimović, Ž. K., Leovac, V. M., Tomić, Z. D. Crystal structure of hexakis(μ2-chloro)-κ4-oxo-tetrakis((3,5-dimethylpyrazole)copper(II)) ethanol tetrasolvate, Cu4OCl6(C5H8N2)4⋯4C2H5OH. Z. Kristallogr. NCS 2007, 222, 246–248; https://doi.org/10.1524/ncrs.2007.0103.Suche in Google Scholar
17. Jaćimović, Ž. K., Kosović, M., Novaković, S. B., Bogdanović, G. A., Giester, G., Kastratović, V. Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl) phenol, C9H7BrN2O. Z. Kristallogr. NCS 2017, 232, 507–509; https://doi.org/10.1515/ncrs-2016-0392.Suche in Google Scholar
18. Jaćimović, Ž. K., Novaković, S. B., Bogdanović, G. A., Kosović, M., Libowitzky, E., Giester, G. Crystal structure of ethyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate, C7H7F3N2O2. Z. Kristallogr. NCS 2020, 235, 1189–1190; https://doi.org/10.1515/ncrs-2020-0242.Suche in Google Scholar
19. Jaćimović, Ž. K., Tomić, Z. D., Giester, G., Libowitzky, E., Ajanović’, A., Kosović’, M. The crystal structure of bis [4-bromo-2-(1H-pyrazol-3-yl)phenolato]-κ2N,O]copper(II), C18H12Br2CuN4O2. Z. Kristallogr. - N. Cryst. Struct. 2021, 236, 1003–1005; https://doi.org/10.1515/ncrs-2021-0191,Suche in Google Scholar
20. Dunitz, J. D., Gavezzotti, A. Supramolecular synthons: validation and ranking of intermolecular interaction energies. Cryst. Growth Des. 2012, 12, 5873–5877; https://doi.org/10.1021/cg301293r.Suche in Google Scholar
21. Llamas-Saiz, A. L., Foces-Foces, C., Cano, F. H., Jiménez, P., Laynez, J., Meutermans, W., Elguero, J., Limbach, H. H., Aguilar-Parrilla, F. The influence of the nitro group on the solid-state structure of 4-nitropyrazoles: the cases of pyrazole, 3,5-dimethylpyrazole, 3,5-di-tert-butylpyrazole and 3,5-diphenylpyrazole. I. Static aspects (crystallography and thermodynamics). Acta Cryst 1994, B50, 746–762; https://doi.org/10.1107/s0108768194004180.Suche in Google Scholar
22. Lieberman, H. F., Davey, R. J., Newsham, D. M. T. Br⋯Br and Br⋯H interactions in action: polymorphism, hopping, and twinning in 1,2,4,5-tetrabromobenzene. Chem. Mater. 2000, 12, 490–494, https://doi.org/10.1021/cm991123p.Suche in Google Scholar
23. Desiraju, G. R., Parthasarathy, R. The nature of halogen-halogen interactions: are short halogen contacts due to specific attractive forces or due to close packing of nonspherical atoms. J. Am. Chem. Soc. 1989, 111, 8725–8726; https://doi.org/10.1021/ja00205a027.Suche in Google Scholar
24. Pejić, M., Popp, S., Bolte, M., Wagner, M., Lerner, H.-W. Functionalized pyrazoles as agents in C–C cross-coupling reactions. Z. Naturforsch. 2014, 69b, 83–97; https://doi.org/10.5560/znb.2014-3224.Suche in Google Scholar
25. Llamas-Saiz, A. L., Foces-Foces, C., Fontenasb, C., Jagerovic, N., Elguerob, J. The search for proton mobility in solid pyrazoles: molecular and crystal structure of 3(5)-phenyl-4-bromo-5(3)-methylpyrazole. J. Mol. Struct. 1999, 484, 197–205; https://doi.org/10.1016/s0022-2860(98)00905-3.Suche in Google Scholar
26. Pedireddi, V. R., Reddy, D. S., Goud, S., Craig, D. C., Raeb, A. B., Desiraju, G. R. The nature of halogen. Halogen interactions and the crystal structure of 1,3,5,7-tetraiodoadamantane. J. Chem. Soc., Perkin Trans. 1994, 2, 2353–2360; https://doi.org/10.1039/p29940002353.Suche in Google Scholar
27. Yan, T., Cheng, G., Yang, H. 1,3,4-Oxadiazole based thermostable energetic materials: synthesis and structure-property relationship. New J. Chem. 2020, 44, 6643–6651; https://doi.org/10.1039/d0nj00518e.Suche in Google Scholar
© 2023 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Artikel in diesem Heft
- Frontmatter
- New Crystal Structures
- The crystal structure of (N-([1,1′:4′,1″-terphenyl]-4,4′-diethyl)-2-(bis(pyridin-2-ylmethyl)amino)acetamide-κ4N,N,N″, O)tri(nitrato-kO, O′) samarium(III) - methanol - acetonitrile (1/1/1), C40H39SmN8O14
- The crystal structure of 6,6′-(((2-(dimethylamino)ethyl)azanediyl)bis(methylene))bis(2-chloro-4-methyl phenolate-κ4N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)-titanium(IV), C27H27Cl2N3O6Ti
- N′-[(1E)-(4–Fluorophenyl)methylidene]adamantane-1-carbohydrazide, C18H21FN2O
- Crystal structure of 4-bromo-3-nitro-1H-pyrazole-5-carboxylic acid monohydrate, C4H2N3BrO4·H2O
- Crystal structure of dipyridine-k1N-tris(2,2,6,6-tetramethyl-5-oxohept-3-en-3-olato-k2O,O′)dysprosium(III), DyC43H67O6N2
- Crystal structure of cyclo[tetraiodido-bis{μ2-1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-isopropyl-imidazol)-k2N:N}dicadmiun(II)], C26H30N10Cd2I4
- The crystal structure of tert-butyl (E)-3-(2-(benzylideneamino)phenyl)-1H-indole-1-carboxylate, C26H24N2O2
- The crystal structure of 4-(3-carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4- dihydroquinolin-7-yl)-2-methylpiperazin-1-ium 2,5-dihydroxybenzoate methanol solvate, C27H32FN3O9
- Crystal structure of (μ2-1-(4,4′-bipyridine-κ2N:N′)-bis[diaqua-(4-iodopyridine-2,6-dicarboxylato-κ3O,N,O′)–cobalt(II)], C24H20Co2I2N4O12
- The crystal structure of dimethyl 4,4′-(10,20-diphenylporphyrin-5,15-diyl)dibenzoate dichloromethane solvate, C49H36N4O4Cl2
- (E)-2-((E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-ylidene)hydrazine-1-carbothioamide C14H23N3S1
- The crystal structure of [1-(4-(trifluoromethyl)phenyl)-3,4-dihydroquinolin-2(1H)-one], C16H12F3NO
- Crystal structure of (E)-2-amino-N′-((3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl)methylene)benzohydrazide – dimethylformamide – water (1/1/2), C15H16N4O3·C3H7NO·2H2O
- Crystal structure of 3-(4-bromophenyl)-5-methyl-1H-pyrazole, C10H9BrN2
- Crystal structure of 1,10-phenanthrolinium bromide dihydrate, C12H9N2Br
- Crystal structure of N-(4′-chloro-[1,1′-biphenyl]-2-yl)formamide, C13H10ClNO
- The crystal structure of nitroterephthalic acid, C8H5NO6
- Crystal structure of (2-((4-bromo-2,6-dichlorophenyl)amino)phenyl) (morpholino)methanone, C17H15BrCl2N2O2
- Crystal structure of tetraaqua-bis(ethanol-κO)-tetrakis(μ2-trifluoroacetate-κ2O:O′)-bis(trifluoroacetate-κ2O)digadolinium(III) Gd2C16H20O18F18
- The crystal structure of dimethyl 4,4′-[10,20-bis(2,6-difluorophenyl)porphyrin-5,15-diyl]dibenzoate chloroform solvate, C50H32Cl6F4N4O4
- The crystal structure of N,N′-((nitroazanediyl)bis(methylene))diacetamide, C6H12O4N4
- The crystal structure of [bis(2,2′-bipyridine-6-carboxylato-κ3N,N,O)magnesium(II)]dihydrate, C22H18N4O6Mg
- Crystal structure of poly[diaqua-(bis(μ2-1,4-bis(imidazol-1-ylmethyl)benzene)-κ2N,N′] cobalt(II)-tetraqua-bis(1,4-bis(imidazol-1-ylmethyl)benzene)-κ1N)-cobalt(II) di(2,5-thiophenedicarboxylate) dihydrate, C68H76Co2N16O16S2
- Crystal structure of poly[chlorido-μ2-chlorido-(μ2-1-[(2-ethyl-4-methyl-1H-imidazol-1-yl)methyl]-1H-benzotriazole-κN:N’)cadmium(II)], C13H15CdN5Cl2
- The crystal structure of (4-hydroxybenzenesulfonate)-k1O-6,6′-((1E,1′E)- (ethane-1,2-diylbis(azaneylylidene))bis(methaneylylidene)) bis(2-methoxyphenol)-κ2N,N,μ2O,O,κ2O, O)-(methanol)-cobalt(II) sodium(I), C25H27CoN2NaO9S
- Crystal structure of (1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)(4-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)amino)piperidin-1-yl)methanone, C17H18F6N6O
- Crystal structure of bis{[(cyclohexylimino)(phenylimino)-l5-(methyl)diethylazane-κ2N:N′]-(ethyl)-zinc(II)]}, C38H62N6Zn2
- Crystal structure of 2-[(4-bromobenzyl)thio]-5-(5-bromothiophen-2-yl)-1,3,4-oxadiazole, C13H8Br2N2OS2
- Crystal structure of 10-methoxy-7,11b,12,13-tetrahydro-6H-pyrazino [2′,3′:5,6]pyrazino[2,1-a]isoquinoline, C15H16N4O
- The crystal structure of 1-propyl-2-nitro-imidazole oxide, C6H9N3O3
- The crystal structure of 3-nitrobenzene-1,2-dicarboxylic acid–2-ethoxybenzamide (1/1), C17H16N2O8
- The structure of RUB-1, (C8H16N)6[B6Si48O108], a boron containing levyne-type zeolite, occluding N-methyl-quinuclidinium in the cage-like pores
- The crystal structure of diaqua-(naphthalene-4,5-dicarboxylate-1,8-dicarboxylic anhydride-κ1O)-(4′-(4-(1H-benzimidazolyl-1-yl)phenyl)-2,2′:6′,2″-terpyridine-κ3N,N′,N″)–manganese(II) dihydrate, C42H27MnN5O9·2H2O
- Crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methanylylidene))bis (3-(3-bromopropoxy)phenol), C20H22Br2N2O4
- The crystal structure of 3-(2-hydroxyphenyl)-4-phenyl-6-(p-tolyl)-2H-pyran-2-one, C24H18O3
- Crystal structure of bis(μ2-2-(1,5-dimethyl–3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino)methyl)phenolato-κ4O:O,N,O′)-(nitrato-κ2O,O′)dicobalt(II), C36H32Co2N8O4
- Synthesis and crystal structure of (3E,5S,10S,13S,14S,17Z)-17-ethylidene-10,13-dimethylhexadecahydro-3H-cyclopenta[α] phenanthren-3-one O-(4-fluorobenzoyl) oxime, C28H36FNO2
- The crystal structure of 4-aminiumbiphenyl benzenesulfonate, C18H17NO3S
- Synthesis and crystal structure of 1-(7-hydroxy-3-(4-hydroxy-3-nitrophenyl)-4-oxo-4H-chromen-8-yl)-N,N-dimethylmethanaminiumnitrate, C18H17N3O9
- Crystal structure of N-(Ar)-N′-(Ar′)-formamidine, C14H12Br2N2O
- The crystal structure of 4-(2,4-dichlorophenyl)-2-(4-fluorophenyl)-5-methyl-1H-imidazole, C16H11Cl2FN2
- Crystal structure of 1-(4–chlorophenyl)-4-benzoyl-3-methyl-1H-pyrazol-5-ol, C17H13ClN2O2
- The crystal structure of 5-amino-1-methyl-4-nitroimidazole, C4H6O2N4
- Crystal structure of 1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene-N,N′-bis(1,3-bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-1,3,2-diazaborol-2-yl)-l2-germenediamine, C63H94B2GeN8
- The crystal structure of (bromido, chlorido)-tricarbonyl-(5,5′-dimethyl-2,2′-bipyridine)-rhenium(I), C15H12Br0.2Cl0.8N2O3Re1
- Crystal structure of [N(E),N′(E)]-N,N′-(1,4-phenylenedimethylidyne)bis-3,5-bis(propan-2-yl)-1H-pyrazol-4-amine, C26H36N6
- The crystal structure of poly[2-(4-carboxypyridin-3-yl)terephthalpoly[diaqua-(μ4-2-(6-carboxylatopyridin-3-yl)terephthalato-κ5O,N:O′:O″,O‴)]) cadmium(II)] dihydrate, C28H20Cd3N2O16
- Crystal structure of [tetraaqua-bis((3-carboxy-5-(pyridin-4-yl)benzoate-κ1N)cobalt(II)] tetrahydrate, C26H32CoN2O16
- Crystal structure of bis(μ2-azido-κ2N:N)-tetrakis(azido-κ1N)-tetrakis(1,10-phenanthroline-κ2N,N′)dibismuth(III), C48H32N26Bi2
- Crystal structure of (Z)-N-(4-(4-(4-((4,5,6-trimethoxy-3-oxobenzofuran-2(3H)-ylidene)methyl)phenoxy)butoxy)phenyl)acetamide, C30H31NO8
- Crystal structure of poly[diaqua-(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2N:N′)-bis(μ2-5-carboxybenzene-1,3-dicarboxylato-O,O′:O″)-aqua-di-zinc dihydrate solvate], C27H28N4O16Zn2
- Crystal structure of 2-(3,5,5-trimethylcyclohex-2-en-1-ylidene)malononitrile, C12H14N2
- Crystal structure of chlorido-(5-nitro-2-phenylpyridine-κ2N,C)-[(methylsulfinyl)methane-κ1S]platinum(II), C13H13ClN2O3PtS
- The crystal structure of the co-crystal 1,4-dioxane–4,6-bis(nitroimino)-1,3,5-triazinan-2-one(2/1), C11H19N7O9
- Crystal structure of [N(E),N′(E)]-N,N′-(1,4-phenylenedimethylidyne)bis-3,5-dimethyl-1H-pyrazol-4-amine di-methanol solvate, C18H20N6·2(CH3OH)
- Crystal structure of catena-poly[bis(μ2-azido-k2N:N′)-(nitrato-K2N:N′)-bis(1,10-phenanthroline-K2N:N′)samarium(III)], C24H16N11O3Sm
- Crystal structure of (Z)-2-(4-((5-bromopentyl)oxy)benzylidene)-4,5,6-trimethoxybenzofuran-3(2H)-one, C23H25BrO6
- Crystal structure of bis(3,5-dimethyl-1H-pyrazol-4-ammonium) tetrafluoroterephthate, 2[C5H10N3][C8F4O4]
- Crystal structure of 2-amino-4-(2-fluoro-4-(trifluoromethyl)phenyl)-9-methoxy-1,4,5,6-tetrahydrobenzo[h]quinazolin-3-ium chloride, C20H18ClF4N3O
- Crystal structure of 6-(pyridin-3-yl)-1,3,5-triazine-2,4-diamine-sebacic acid (2/1), C13H17N6O2
Artikel in diesem Heft
- Frontmatter
- New Crystal Structures
- The crystal structure of (N-([1,1′:4′,1″-terphenyl]-4,4′-diethyl)-2-(bis(pyridin-2-ylmethyl)amino)acetamide-κ4N,N,N″, O)tri(nitrato-kO, O′) samarium(III) - methanol - acetonitrile (1/1/1), C40H39SmN8O14
- The crystal structure of 6,6′-(((2-(dimethylamino)ethyl)azanediyl)bis(methylene))bis(2-chloro-4-methyl phenolate-κ4N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)-titanium(IV), C27H27Cl2N3O6Ti
- N′-[(1E)-(4–Fluorophenyl)methylidene]adamantane-1-carbohydrazide, C18H21FN2O
- Crystal structure of 4-bromo-3-nitro-1H-pyrazole-5-carboxylic acid monohydrate, C4H2N3BrO4·H2O
- Crystal structure of dipyridine-k1N-tris(2,2,6,6-tetramethyl-5-oxohept-3-en-3-olato-k2O,O′)dysprosium(III), DyC43H67O6N2
- Crystal structure of cyclo[tetraiodido-bis{μ2-1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-isopropyl-imidazol)-k2N:N}dicadmiun(II)], C26H30N10Cd2I4
- The crystal structure of tert-butyl (E)-3-(2-(benzylideneamino)phenyl)-1H-indole-1-carboxylate, C26H24N2O2
- The crystal structure of 4-(3-carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4- dihydroquinolin-7-yl)-2-methylpiperazin-1-ium 2,5-dihydroxybenzoate methanol solvate, C27H32FN3O9
- Crystal structure of (μ2-1-(4,4′-bipyridine-κ2N:N′)-bis[diaqua-(4-iodopyridine-2,6-dicarboxylato-κ3O,N,O′)–cobalt(II)], C24H20Co2I2N4O12
- The crystal structure of dimethyl 4,4′-(10,20-diphenylporphyrin-5,15-diyl)dibenzoate dichloromethane solvate, C49H36N4O4Cl2
- (E)-2-((E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-ylidene)hydrazine-1-carbothioamide C14H23N3S1
- The crystal structure of [1-(4-(trifluoromethyl)phenyl)-3,4-dihydroquinolin-2(1H)-one], C16H12F3NO
- Crystal structure of (E)-2-amino-N′-((3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl)methylene)benzohydrazide – dimethylformamide – water (1/1/2), C15H16N4O3·C3H7NO·2H2O
- Crystal structure of 3-(4-bromophenyl)-5-methyl-1H-pyrazole, C10H9BrN2
- Crystal structure of 1,10-phenanthrolinium bromide dihydrate, C12H9N2Br
- Crystal structure of N-(4′-chloro-[1,1′-biphenyl]-2-yl)formamide, C13H10ClNO
- The crystal structure of nitroterephthalic acid, C8H5NO6
- Crystal structure of (2-((4-bromo-2,6-dichlorophenyl)amino)phenyl) (morpholino)methanone, C17H15BrCl2N2O2
- Crystal structure of tetraaqua-bis(ethanol-κO)-tetrakis(μ2-trifluoroacetate-κ2O:O′)-bis(trifluoroacetate-κ2O)digadolinium(III) Gd2C16H20O18F18
- The crystal structure of dimethyl 4,4′-[10,20-bis(2,6-difluorophenyl)porphyrin-5,15-diyl]dibenzoate chloroform solvate, C50H32Cl6F4N4O4
- The crystal structure of N,N′-((nitroazanediyl)bis(methylene))diacetamide, C6H12O4N4
- The crystal structure of [bis(2,2′-bipyridine-6-carboxylato-κ3N,N,O)magnesium(II)]dihydrate, C22H18N4O6Mg
- Crystal structure of poly[diaqua-(bis(μ2-1,4-bis(imidazol-1-ylmethyl)benzene)-κ2N,N′] cobalt(II)-tetraqua-bis(1,4-bis(imidazol-1-ylmethyl)benzene)-κ1N)-cobalt(II) di(2,5-thiophenedicarboxylate) dihydrate, C68H76Co2N16O16S2
- Crystal structure of poly[chlorido-μ2-chlorido-(μ2-1-[(2-ethyl-4-methyl-1H-imidazol-1-yl)methyl]-1H-benzotriazole-κN:N’)cadmium(II)], C13H15CdN5Cl2
- The crystal structure of (4-hydroxybenzenesulfonate)-k1O-6,6′-((1E,1′E)- (ethane-1,2-diylbis(azaneylylidene))bis(methaneylylidene)) bis(2-methoxyphenol)-κ2N,N,μ2O,O,κ2O, O)-(methanol)-cobalt(II) sodium(I), C25H27CoN2NaO9S
- Crystal structure of (1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)(4-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)amino)piperidin-1-yl)methanone, C17H18F6N6O
- Crystal structure of bis{[(cyclohexylimino)(phenylimino)-l5-(methyl)diethylazane-κ2N:N′]-(ethyl)-zinc(II)]}, C38H62N6Zn2
- Crystal structure of 2-[(4-bromobenzyl)thio]-5-(5-bromothiophen-2-yl)-1,3,4-oxadiazole, C13H8Br2N2OS2
- Crystal structure of 10-methoxy-7,11b,12,13-tetrahydro-6H-pyrazino [2′,3′:5,6]pyrazino[2,1-a]isoquinoline, C15H16N4O
- The crystal structure of 1-propyl-2-nitro-imidazole oxide, C6H9N3O3
- The crystal structure of 3-nitrobenzene-1,2-dicarboxylic acid–2-ethoxybenzamide (1/1), C17H16N2O8
- The structure of RUB-1, (C8H16N)6[B6Si48O108], a boron containing levyne-type zeolite, occluding N-methyl-quinuclidinium in the cage-like pores
- The crystal structure of diaqua-(naphthalene-4,5-dicarboxylate-1,8-dicarboxylic anhydride-κ1O)-(4′-(4-(1H-benzimidazolyl-1-yl)phenyl)-2,2′:6′,2″-terpyridine-κ3N,N′,N″)–manganese(II) dihydrate, C42H27MnN5O9·2H2O
- Crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methanylylidene))bis (3-(3-bromopropoxy)phenol), C20H22Br2N2O4
- The crystal structure of 3-(2-hydroxyphenyl)-4-phenyl-6-(p-tolyl)-2H-pyran-2-one, C24H18O3
- Crystal structure of bis(μ2-2-(1,5-dimethyl–3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino)methyl)phenolato-κ4O:O,N,O′)-(nitrato-κ2O,O′)dicobalt(II), C36H32Co2N8O4
- Synthesis and crystal structure of (3E,5S,10S,13S,14S,17Z)-17-ethylidene-10,13-dimethylhexadecahydro-3H-cyclopenta[α] phenanthren-3-one O-(4-fluorobenzoyl) oxime, C28H36FNO2
- The crystal structure of 4-aminiumbiphenyl benzenesulfonate, C18H17NO3S
- Synthesis and crystal structure of 1-(7-hydroxy-3-(4-hydroxy-3-nitrophenyl)-4-oxo-4H-chromen-8-yl)-N,N-dimethylmethanaminiumnitrate, C18H17N3O9
- Crystal structure of N-(Ar)-N′-(Ar′)-formamidine, C14H12Br2N2O
- The crystal structure of 4-(2,4-dichlorophenyl)-2-(4-fluorophenyl)-5-methyl-1H-imidazole, C16H11Cl2FN2
- Crystal structure of 1-(4–chlorophenyl)-4-benzoyl-3-methyl-1H-pyrazol-5-ol, C17H13ClN2O2
- The crystal structure of 5-amino-1-methyl-4-nitroimidazole, C4H6O2N4
- Crystal structure of 1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene-N,N′-bis(1,3-bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-1,3,2-diazaborol-2-yl)-l2-germenediamine, C63H94B2GeN8
- The crystal structure of (bromido, chlorido)-tricarbonyl-(5,5′-dimethyl-2,2′-bipyridine)-rhenium(I), C15H12Br0.2Cl0.8N2O3Re1
- Crystal structure of [N(E),N′(E)]-N,N′-(1,4-phenylenedimethylidyne)bis-3,5-bis(propan-2-yl)-1H-pyrazol-4-amine, C26H36N6
- The crystal structure of poly[2-(4-carboxypyridin-3-yl)terephthalpoly[diaqua-(μ4-2-(6-carboxylatopyridin-3-yl)terephthalato-κ5O,N:O′:O″,O‴)]) cadmium(II)] dihydrate, C28H20Cd3N2O16
- Crystal structure of [tetraaqua-bis((3-carboxy-5-(pyridin-4-yl)benzoate-κ1N)cobalt(II)] tetrahydrate, C26H32CoN2O16
- Crystal structure of bis(μ2-azido-κ2N:N)-tetrakis(azido-κ1N)-tetrakis(1,10-phenanthroline-κ2N,N′)dibismuth(III), C48H32N26Bi2
- Crystal structure of (Z)-N-(4-(4-(4-((4,5,6-trimethoxy-3-oxobenzofuran-2(3H)-ylidene)methyl)phenoxy)butoxy)phenyl)acetamide, C30H31NO8
- Crystal structure of poly[diaqua-(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2N:N′)-bis(μ2-5-carboxybenzene-1,3-dicarboxylato-O,O′:O″)-aqua-di-zinc dihydrate solvate], C27H28N4O16Zn2
- Crystal structure of 2-(3,5,5-trimethylcyclohex-2-en-1-ylidene)malononitrile, C12H14N2
- Crystal structure of chlorido-(5-nitro-2-phenylpyridine-κ2N,C)-[(methylsulfinyl)methane-κ1S]platinum(II), C13H13ClN2O3PtS
- The crystal structure of the co-crystal 1,4-dioxane–4,6-bis(nitroimino)-1,3,5-triazinan-2-one(2/1), C11H19N7O9
- Crystal structure of [N(E),N′(E)]-N,N′-(1,4-phenylenedimethylidyne)bis-3,5-dimethyl-1H-pyrazol-4-amine di-methanol solvate, C18H20N6·2(CH3OH)
- Crystal structure of catena-poly[bis(μ2-azido-k2N:N′)-(nitrato-K2N:N′)-bis(1,10-phenanthroline-K2N:N′)samarium(III)], C24H16N11O3Sm
- Crystal structure of (Z)-2-(4-((5-bromopentyl)oxy)benzylidene)-4,5,6-trimethoxybenzofuran-3(2H)-one, C23H25BrO6
- Crystal structure of bis(3,5-dimethyl-1H-pyrazol-4-ammonium) tetrafluoroterephthate, 2[C5H10N3][C8F4O4]
- Crystal structure of 2-amino-4-(2-fluoro-4-(trifluoromethyl)phenyl)-9-methoxy-1,4,5,6-tetrahydrobenzo[h]quinazolin-3-ium chloride, C20H18ClF4N3O
- Crystal structure of 6-(pyridin-3-yl)-1,3,5-triazine-2,4-diamine-sebacic acid (2/1), C13H17N6O2